RESEARCHER PROFILE

JC Orengo

← Back to Ponce Health Sciences University

J

Ponce Health Sciences University

Breast Cancer Treatment StudiesMicrotubule and mitosis dynamicsCancer Cells and MetastasisCervical Cancer and HPV ResearchGlobal Cancer Incidence and Screening

JC Orengo works in Breast Cancer Treatment Studies, Microtubule and mitosis dynamics, Cancer Cells and Metastasis, Cervical Cancer and HPV Research, Global Cancer Incidence and Screening. Recorded institutional associations include Ponce Health Sciences University.

16Publications
14Citations
1H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Mitotic kinases are emerging therapeutic targets against metastatic breast cancer

    2024 · 13 citations
  2. PCV39 THE PUERTO RICO CARDIOVASCULAR RISK ESTIMATION STUDY (PRCARES): AN EXPLORATORY ASSESSMENT OF NEW PATIENTS IN PHYSICIANS' OFFICES

    2010 · 1 citations
  3. The Burden of Cancer in Jamaica

    2015 · 0 citations
  4. Geographic distribution of risk of death due to homicide in Puerto Rico, 2000–2007

    2010 · 0 citations
  5. Change In The Demographic Profile And Impact In The Mortality Of Melanoma And Lung Cancer In Puerto Rico 2000-2010

    2015 · 0 citations
  6. EE244 Estimating Treatment Cost Savings of Gender-Neutral Nonavalent HPV Vaccination in Mexico

    2024 · 0 citations
  7. Abstract C151: Single and combined inhibition of AURKA and AURKB promotes a decrease in the expression of EMT biomarkers and transcription factors in triple-negative breast cancer in women of African ancestry

    2024 · 0 citations
  8. Abstract C141: Inactivating the mitotic kinases TTK and NEK2 as a promising approach for the reduction of metastasis in triple-negative breast cancer in non-Hispanic Blacks and Hispanic/Latinas

    2024 · 0 citations
  9. EPH12 Hospitalization Rates of HPV-Associated Cancers in Brazil From 2011-2019

    2024 · 0 citations
  10. EPH11 Burden of HPV-Associated Cancers in Mexico From 2011-2019

    2024 · 0 citations
  11. EE211 The Indirect Costs and Burden of Vaccine Preventable Cancers Mortality in Latin American Region

    2024 · 0 citations
  12. Abstract 6949: Downregulating the mitotic kinases TTK and NEK2 as a promising approach for the reduction of metastasis in triple-negative breast cancer cell lines

    2025 · 0 citations
  13. Abstract 5456: Multiplatform bioinformatic profiling identifies TTK and NEK2 as survival-associated drivers in triple-negative breast cancer.

    2026 · 0 citations
  14. Abstract 7165: The role of NEK2 and AURKB on triple-negative breast cancer progression

    2026 · 0 citations
  15. Abstract 320: Targeting overexpressed TTK and NEK2 decreases early metastatic potential of triple-negative breast cancer cell lines.

    2026 · 0 citations
  16. Abstract 333: Downregulation of AURKA and AURKB promotes a decrease in cell invasion in TNBC by modulating the expression of SNAIL1.

    2026 · 0 citations

← Return to the university profile